There is over $70B in unclaimed property across the U.S., held by state agencies.

Search public records using your name and state to check for possible matches, including funds from accounts, refunds, or deposits.

Search & Claim Funds

You ghost your own socials by Wednesday. SureThing learns your voice and ships native posts to LinkedIn, X, Instagram, and TikTok, without you writing a thing.

Post in Your Voice

I saw a business case I wrote in 2001.

Beginning January 1, 2028, nearly every acute care hospital in the country will be financially accountable for the full 90 days of a Medicare patient's recovery after a hip, knee, or ankle replacement. It's called the Comprehensive Care for Joint Replacement Expanded Model (CJR-X) and it is the first time CMS has taken an episode-based payment model national and made it mandatory beyond certain geographic regions.

Nothing in the clinical evidence changed between 2001 and Friday. Patients recovering from a routine knee replacement were up and walking in a day or two then, and they are up and walking in a day or two now. What changed is who pays for the difference.

I came to home health full-time in 2001. I'd been working in an inpatient rehabilitation facility, then outpatient neuro and ortho, plus a sports medicine clinic I helped open, plus moonlighting in home health because my fiancé and I were saving for a house and I was trying to make every dollar I could.

When I transitioned to home health full-time, I brought something with me from the rehab hospital that I couldn't let go of.

In inpatient rehab, my caseload was typically three patients at a time every 90 minutes. These were patients with massive strokes. Traumas. Amputations. Patients I could not transfer without a PT aide, because we were talking max assist. I was 23 and I could do it. IRFs are for youth 😁

And I learned to make my own schedule as doable as possible. When I built a group of three, I'd try to make sure at least one of them was a total joint replacement patient. Why? Because that patient needed a little supervision and some cueing, and within a few days, they'd be up and walking well. They were my breathing room. They were much less likely to have major safety issues.

That's when it stopped making sense to me.

These were otherwise healthy people who'd had an elective knee or hip replaced. They were motivated. They had an excellent prognosis. They were sitting in the most intensive rehabilitation setting Medicare pays for, next to a patient with a hemorrhagic stroke. And the thing is, I could not construct a clinical argument for why.

So I went looking for the number. Medicare was paying somewhere around $17,000 for those stays. The patient was there a week and a half at the most, went home, and then came back to the same building for outpatient therapy.

I couldn't make that math mean anything.

So I said to my new manager: I don't understand why the patients our hospital operates on go to inpatient rehab and we never see them. They go straight from an institution to outpatient. A side effect that’s not great for home health is we're not in the picture at all.

What if they went home instead?

Not with less therapy. With different therapy setting. Five or six visits that first week, in the house where they actually have to negotiate their own stairs and their own bathroom. A couple of weeks of that, then a clean handoff to outpatient.

Lower infection risk. One fewer care transition. A person recovering in their own bed.

And the reimbursement worked. A 60-day home health episode at the time was somewhere around $3,000. The nonroutine supply costs were near nothing, and the patients were a joy to treat: motivated, with a great prognosis and visible progress every visit

We wrote the business case. We named it “Rapid Rehab.” And we took it to home health leadership and eventually, to the orthopedic surgeons.

The surgeons did not love it.

Under the old arrangement, a patient went to inpatient rehab and a different physician assumed responsibility for the day-to-day. “Rapid Rehab” meant the surgeons stayed slightly more engaged in the first couple of weeks and fielded calls from home health.

The acute care hospitals weren't thrilled either. Discharging to a facility meant a liaison handled the transition, whereas discharging home meant their own staff had to coordinate orders, pharmacy, and wound care.

And the inpatient rehab facilities, understandably, did not want to lose their most straightforward, low medical complexity admissions.

Every one of those incentives was rational. But none of them belonged to the patient.

That is not villainy. It's design. A great many things in healthcare that make no clinical sense make perfect financial sense for somebody. Learning to see whom is most of the skill.

We eventually won over a percentage of the orthopedic practices. Where there was friction, they didn't send patients. Where it ran smoothly, they did.

But the first real enthusiasm came from two places I didn't expect.

Hospital for Special Surgery, across the river in NYC, was a customer earlier on, transitioning some of their patients to “Rapid Rehab” so they could go straight home. Some patients with Medicare Advantage plans also followed suit to utilize the safe, lower-cost alternative. There was simply no medical reason these patients couldn't recover at home.

By the mid-2000s we were a well-oiled machine.

We essentially implemented a value-based episode for patients that were status post total joint replacement a decade before CJR existed.

So when BPCI and the original CJR model arrived and hospitals were suddenly at risk for the total cost of a joint replacement episode, our transition was almost boring. We'd been doing the work. I credit some of that early willingness with why, when the ACA landed, our system built its population health department out of home health leadership.

On January 1, 2028, nothing about how you get paid changes. That is the part people miss.

CMS is not cutting one check. Everyone still bills normally, including the hospital, the surgeon, the anesthesiologist, the SNF, the home health agency, the outpatient clinic. The money moves exactly as it does today.

Then, retrospectively, CMS adds up everything Medicare paid for that patient from the procedure through 90 days post-discharge and compares it to a target price built for that specific patient. CJR-X uses 29 risk adjusters, including age, Hierarchical Condition Category (HCC) count, dual eligibility, procedure type, disability as original reason for entitlement, prior post-acute use, and 21 specific HCCs (which is a major upgrade from the three the original CJR used, and it's the same set TEAM uses).

Come in under target with acceptable quality, the hospital shares in the savings. Come in over, the hospital owes some of it back. Quality comes first: hospitals have to clear a minimum composite quality score before they see a reconciliation payment at all, and that score includes a patient-reported outcome measure for hip and knee replacement.

There's no end date. It's an expansion, not a test.

Note: CMS originally proposed an October 1, 2027 start. Hospital associations pushed back hard on the mandatory design and asked for a phased, voluntary, or observation-only ramp-up. What they got was a three-month delay to January 1, 2028. The model itself was finalized broadly as proposed.

Count from Friday and you have about seventeen months. That is the runway.

And CJR-X sits on top of TEAM, which has been running since January 2026 in 188 markets with 30-day episodes across five surgical categories. TEAM hospitals are carved out of CJR-X, but when TEAM ends, they roll in.

The evaluations of the original CJR model are unambiguous about where the savings came from. Lower episode spending, no meaningful increase in complications, and the reduction driven almost entirely by fewer discharges to institutional post-acute care. That's it. That's the mechanism.

So let me put the current numbers next to each other.

In 2024, Medicare's average payment was $1,937 for a 30-day home health period and $25,300 for an inpatient rehabilitation stay averaging 12.4 days.

Now hold that $25,300 against this: the average total 90-day joint replacement episode in 2024, including surgery, hospitalization, and every post-acute service across the whole recovery, cost Medicare about $19,179.

A single average IRF stay costs more than the average entire episode CJR-X will hold hospitals accountable for. One discharge decision can consume the whole budget and then some.

Be fair to the comparison: that $19,179 comes from a claims analysis that excludes professional fees, anesthesia, and durable medical equipment, so real episode cost runs higher. It is still the closest thing we have to a current national average.

Home health for the same patient: the CY 2026 standardized 30-day period is $2,038.22. A post-surgical joint replacement patient groups as musculoskeletal rehabilitation, institutional admission source, early period, then gets adjusted for functional impairment and comorbidity. Most of these patients need one period. Some need two. And there is no beneficiary cost sharing for home health at all, while an IRF stay carries the inpatient deductible — $1,736 in 2026 — if the patient hasn't already met it.

Out of curiosity, I went back to the CJR evaluation and worked out what an IRF stay for a joint replacement patient actually ran in the model's baseline years. The arithmetic lands right around $16,000.

And the direction of travel is the wrong one. Between 2015 and 2024, IRF volume per beneficiary rose 31 percent while per-capita IRF spending rose 56 percent. SNF volume fell 35 percent. Home health volume fell too. IRFs went from 3.7 percent of hospital discharges in 2019 to 5.3 percent in 2024. MedPAC attributes part of that growth to an increase in the number of IRFs.

I want to be careful here, because I trained in an IRF and I believe in that level of care. Stroke, for examples, is a condition where the evidence consistently favors it. But the evidence for routine joint replacement points the other way.

A Hospital for Special Surgery registry study with 1,213 propensity-matched pairs found no functional or patient-reported advantage to inpatient rehab after primary TKA. More recent National Surgical Quality Improvement Program (NSQIP) work found higher complication and readmission rates with discharge to an inpatient facility versus home. And when financial incentives pushed patients home in Pennsylvania, matched cohorts had fewer readmissions and no difference in complications or mortality.

If you work in a hospital that has never been in an episode model, and your default after a total joint is still "call the liaison," January 1, 2028 is your deadline.

Start now. And start with the things that are entirely inside your control (these are ideas only and are not intended to be read as advice):

Learn how your hospital's target prices get built. Ask who owns the CJR-X reconciliation. If the answer is "nobody yet," that is an opening.

Don't build your career memorizing rules, because rules are the output.

Build it on noticing. The workflow everybody complains about. The patient journey with a step in it nobody can justify. The process that survives because that's how we've always done it. Ask yourself: if we designed this from a true patient-centered approach today, would it still look like this?

Sometimes the honest answer is yes, and you move on. Sometimes it's no, and then ask the second question, which is the one that actually matters: who benefits from the current arrangement, and what would have to change for the upside to land on the patient instead?

At 26, I could not have told you that CMS would one day require what I was arguing for. I only knew it didn't make sense, and I learned that saying so made things uncomfortable for surgeons and hospitals and post-acute facilities that were doing fine under the existing setup.

Here's what I ask you to consider: if you're someone who notices these things, who thinks about progress and patient experience and what all of this is costing, you're on the right side of history. And if you're somewhere that can't see it, start thinking hard about where else you might work so you can. Your career is going to depend on your ability to see around this particular corner.

The future usually starts with somebody quietly asking why we're doing it this way.

The rule itself, and the confirmation of the January 1, 2028 start date. Centers for Medicare & Medicaid Services, "FY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule (CMS-1849-F)," July 31, 2026. cms.gov · The full rule, all 2,704 pages of it, with CJR-X codified at 42 CFR Part 510, Subpart F: federalregister.gov

CMS's own framing of why it expanded the model, including the savings figure it's leaning on. The agency puts the original CJR Model's savings at more than $100 million while maintaining quality, and describes CJR-X as the first expanded mandatory test of an episode-based payment model. Centers for Medicare & Medicaid Services, "CMS Announces Nationwide Expansion of Proven Joint Replacement Program," July 31, 2026. cms.gov

The model page: episode definition, the qualifying MS-DRGs and HCPCS codes, the five quality measures, the 29 risk adjusters, and the safety-net and rural stop-loss protections. Centers for Medicare & Medicaid Services Innovation Center, "CJR-X (Comprehensive Care for Joint Replacement Expanded) Model." cms.gov

Why the start date moved, and by how much. Muoio, D. "CMS locks in 2.3% inpatient hospital base pay increase, nudges back CJR-X Model start date." Fierce Healthcare, July 31, 2026. fiercehealthcare.com

What a 90-day joint replacement episode actually costs today, and the source for the $19,179 figure. Trilliant Health, "Episode Cost and Quality Are Not Correlated Across Hospitals Subject to Mandatory LEJR Bundled Payment Under TEAM and Proposed CJR-X," June 4, 2026. trillianthealth.substack.com

Where the IRF payment mechanics come from, if you want to price out a specific patient. Centers for Medicare & Medicaid Services, "Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027," 91 FR 17195. federalregister.gov · Final rule fact sheet, July 30, 2026: cms.gov · Addenda and rate files: cms.gov

Where the home health side of the comparison comes from. if you don't want to open the rule. Centers for Medicare & Medicaid Services, "Calendar Year (CY) 2026 Home Health Prospective Payment System Final Rule (CMS-1828-F)," November 28, 2025. cms.gov · How the four PDGM variables combine into a payment group: cms.gov

The evaluation I used to work out what an IRF stay for a joint replacement patient actually cost. The Lewin Group for CMS, "CMS Comprehensive Care for Joint Replacement Model: Performance Year 7 Evaluation In-Depth Report," December 2025. cms.gov

The single most important document for understanding where the money actually is. Medicare Payment Advisory Commission, "Post-Acute Care: Trends and Key Issues," Chapter 6, Report to the Congress: Medicare Payment Policy, March 2026. medpac.gov

The peer-reviewed evaluation establishing that CJR's savings came from discharge disposition, not from anything else. Barnett ML, Wilcock A, McWilliams JM, et al. "Two-Year Evaluation of Mandatory Bundled Payments for Joint Replacement." N Engl J Med 2019;380:252-262. nejm.org

The registry study that found no functional or patient-reported benefit to inpatient rehab after primary TKA, from Hospital for Special Surgery, of all places. Padgett DE, Christ AB, Joseph AD, Lee YY, Haas SB, Lyman S. "Discharge to Inpatient Rehab Does Not Result in Improved Functional Outcomes Following Primary Total Knee Arthroplasty." J Arthroplasty 2018;33(6):1663-1667. pubmed.ncbi.nlm.nih.gov

More recent evidence pointing the same direction, using NSQIP data from 2015 to 2020. Whitaker S, Cole S, Peri M, et al. "Higher complication and readmission rates after total knee arthroplasty with discharge to inpatient facility vs. home: a propensity score matched analysis." J Orthop Surg Res 2024;19:806. josr-online.biomedcentral.com

The natural experiment: what happened to outcomes when payment incentives actually moved patients home. "Association of Discharge to Home vs Institutional Postacute Care With Outcomes After Lower Extremity Joint Replacement." JAMA Network Open, 2020. pmc.ncbi.nlm.nih.gov

The model CJR-X sits alongside, and the reason some hospitals won't be in CJR-X on day one. Centers for Medicare & Medicaid Services Innovation Center, "Transforming Episode Accountability Model (TEAM)." cms.gov

Background on the home health payment system I walked into in 2001, and why my manager was suddenly hiring full-time therapists. Centers for Medicare & Medicaid Services, "Home Health PPS." cms.gov

The clinical levers, part one: preserving the quadriceps. Kuang MJ, Xu LY, Ma JX, et al. "Adductor canal block versus femoral nerve block for total knee arthroplasty: a meta-analysis of randomized controlled trials." Scientific Reports 2017;7:40721. nature.com

The clinical levers, part two: getting them up. Guerra ML, Singh PJ, Taylor NF. "Early mobilization of patients who have had a hip or knee joint replacement reduces length of stay in hospital: a systematic review." Clinical Rehabilitation 2015;29(9):844-854. journals.sagepub.com

Where total healthcare spending is heading, and why "cost is somebody else's problem" is no longer a viable clinical posture. PwC Health Research Institute, "Medical Cost Trend: Behind the Numbers 2027," June 2026. pwc.com

*Disclaimer: All opinions and ideas expressed in this article are solely mine and none represent a recommendation or should be viewed as advisement of any kind to anyone to do anything.*